Literature DB >> 28966040

Evolution and prognosis of intramural aortic hematoma. Insights from a midterm cohort study.

Carlos Ferrera1, Isidre Vilacosta2, Juan Carlos Gómez-Polo2, Sara Villanueva-Medina2, Beatriz Cabeza3, Luis Ortega4, Victoria Cañadas2, Manuel Carnero-Alcázar2, Isaac Martínez-López2, Luis Maroto-Castellanos2, Francisco Javier Serrano-Hernando2.   

Abstract

BACKGROUND: Although several hypotheses have been proposed, the true origin and pathogenesis of aortic intramural hematoma (IMH) remain unclear. Evolution of patients with aortic IMH is highly variable. Progression to classic aortic dissection, aneurysm or to complete resolution have been described. Our purpose was to assess in-hospital and mid-term evolution of patients with aortic IMH.
METHODS: From 2000 to 2015, 40 patients with aortic IMH were prospectively and consecutively recruited in a tertiary care referral center. Aortic IMH was defined as the presence of a circular or crescent-shaped thickening of the aortic wall (≥5mm) in the absence of detectable blood flow inside, within the context of acute aortic syndrome.
RESULTS: Twenty three patients (57.5%) had type A, and 17 (42.5%) type B IMH. Up to 34.7% of patients with type A and 47.1% with type B IMH showed intimal tears in the imaging test at admission. In-hospital mortality was higher in the type A IMH group. All-cause mortality after discharge was 20%, without significant differences among groups. Out of hospital death was related to the aortic pathology in just one patient. At follow-up, radiological persistence of IMH was observed in 35.7% of patients with type A and 60% of those with type B IMH.
CONCLUSIONS: IMH related mortality takes place primarily during the acute phase of the disease. Clinical evolution after discharge is favorable, either in cases of reabsorption or persistence of the IMH. Imaging test findings rekindle the debate on the true training mechanism of the aortic IMH.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aortic disease; Aortic intramural hematoma; Prognosis

Mesh:

Year:  2017        PMID: 28966040     DOI: 10.1016/j.ijcard.2017.09.170

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  6 in total

1.  Endovascular versus medical management of type B intramural hematoma: a meta-analysis.

Authors:  Adam Chakos; Tisha Twindyawardhani; Arturo Evangelista; Giuliana Maldonado; Gabriele Piffaretti; Tristan D Yan; David H Tian
Journal:  Ann Cardiothorac Surg       Date:  2019-07

Review 2.  Diagnosing Aortic Intramural Hematoma: Current Perspectives.

Authors:  Carlos Ferrera; Isidre Vilacosta; Beatriz Cabeza; Javier Cobiella; Isaac Martínez; Melchor Saiz-Pardo Sanz; Ana Bustos; Francisco Javier Serrano; Luis Maroto
Journal:  Vasc Health Risk Manag       Date:  2020-06-08

3.  Prognostic value of estimated glomerular filtration rate and presence of proteinuria in type B aortic intramural hematoma.

Authors:  Yang Yang; Weihao Li; Mingyuan Liu; Xiaoming Zhang; Qingle Li
Journal:  J Thorac Dis       Date:  2021-02       Impact factor: 2.895

4.  Clinical medical decision-making of acute aortic intramural hematoma: A non-randomized retrospective case study.

Authors:  Hao Qin; Li Wei; Bo Zhang; Yujing Wang; Yamin Liu
Journal:  J Interv Med       Date:  2020-07-09

Review 5.  Surgery for type A intramural hematoma: a systematic review of clinical outcomes.

Authors:  David H Tian; Adam Chakos; Lucy Hirst; Sally T W Chung; Tristan D Yan
Journal:  Ann Cardiothorac Surg       Date:  2019-09

6.  Evaluation of Surgical Outcomes of Type A Intramural Hematoma.

Authors:  Tugra Gencpinar; Reha Topak; Ozkan Alatas; Aytac Gulcu; Serdar Bayrak; Cenk Erdal
Journal:  Braz J Cardiovasc Surg       Date:  2022-03-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.